Press Сentre
Наши новости
Avineiro, a company of the ChemRar group, the owner of the registration certificate for the drug Aviandr®, announces that the active ingredient of the drug has been assigned the international non-proprietary name (INN) Maritupirdine. This is an official recognition of the uniqueness and innovation of the Russian molecule and its inclusion in the ...
18.06.2025
CDRI Production Company (ChemRar Group) has successfully confirmed its compliance with GMP standards
The Chemical Diversity Research Institute (CDRI LLC , part of the ChemRar Group, Khimki, Moscow Region) has successfully passed the inspection of the Ministry of Industry and Trade of the Russian Federation and received an updated GMP certificate, confirming the current license for the production of medicines for medical use.
During the ...
26.05.2025
On May 19, 2025, as part of the celebration of the Day of the Pharmaceutical Worker of Russia, established last year by the Ministry of Industry and Trade of the Russian Federation, the first solemn ceremony was held to award pharmaceutical industry workers to the management staff of pharmaceutical companies, representatives of industry ...
19.05.2025
The expert believes that the first signs of degradation have appeared in the industry. To ensure real technological sovereignty it is necessary to replace 9% of INN of own innovative drugs. Such targets were announced at the meeting of the Expert Council in the State Duma, dedicated to the problems o pharma innovations development in 2025-2036.
...
14.02.2025
“HIV Infection: Transformation of Approaches and Effective Balance” IV All-Russian Congress with International Participation was held on December 19-20 in Moscow at the Analytical Center under the Government of the Russian Federation.
Andrey Ivashchenko, the Chairman of the Board of Directors of ChemRar Group took part in the business program ...
28.12.2024
On October 7, 2024, at the Gelendzhik Arena, “Development of Innovative Drugs As Condition for Technological Sovereignty of the Russian Federation in Pharmaceuticals” panel discussion was held within the framework of the Biotechmed-2024 Forum. The panel discussion was prepared with the support of ChemRar Group of Companies and the Innovative ...
25.10.2024
ChemRar Group, the domestic market leader in the development and manufacture of innovative pharmaceuticals, is expanding its manufacturing capacity by building a new high-tech complex that will include the manufacture of active pharmaceutical ingredients, storage facilities and a workshop for the development of intermediates for APIs.
...
19.09.2024
If we consider pharmaceuticals to be an industry where we should have technological sovereignty, then we should have not only fully localized pharmaceutical manufacturing facilities, but also our own development lines for innovative drugs.
On June 5, 2024, Andrey Ivashchenko, Chairman of the Board of Directors of ChemRar Group, Doctor of ...
14.06.2024
On June 5, within the framework of SPIEF, a session dedicated to the development of domestic innovative pharmaceuticals was held with the organizational support of Innopraktika Company and the National Champions Association.
As part of the discussion, the speakers considered the specifics of development, introduction into manufacture and launch ...
07.06.2024
Artificial Intelligence (AI) is now actively used in various industries, transforming and improving the processes efficiency. Medicine and pharmaceuticals are no exception, they are industries where AI technologies are being introduced into routine practice.
Development of new drugs is a long and expensive process; it is assumed that AI, by ...
27.04.2024
ChemRar Group and Pharmaceutical Health Corporation S.A.S, national pharmaceutical distributor in Colombia, announce the signing of the agreement for the supply of five anticancer products: TEMOSOLOMIDE (INN Temozolomide), LANGOTER (INN Gefitinib), SUNITINIB-CHEMRAR (INN Sunitinib), POTARBIN (INN Pazopanib) and LAPATINIB-CHEMRAR (INN Lapatinib). ...
15.04.2024
Andrey Aleksandrovich Ivashchenko, the Chairman of the Board of Directors of ChemRar Group, spoke at “Road to Sovereignty in Pharma and Healthcare” discussion organized by Kommersant Publishing House.
In June 2023, the Russian Government approved the Pharma-2030 Pharmaceutical Industry Development Strategy prepared by the Russian Ministry of ...
08.04.2024
Публикации в печатных и электронных СМИ
Видео
Фото
